Article Per Year (5 Year)
p-Index From 2021 - 2026
4.925
P-Index
This Author published in this journals
All Journal INDONESIAN JOURNAL OF PHARMACY Jurnal Surya Medika JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Majalah Farmaseutik JFIOnline Jurnal Ilmu Kefarmasian Indonesia PREPOTIF : Jurnal Kesehatan Masyarakat Journal of Holistics and Health Sciences (JHHS) Generics: Journal of Research in Pharmacy Jurnal Farmasi Sains dan Praktis Academic Hospital Journal Generics : Journal of Research in Pharmacy Jurnal Kefarmasian Indonesia
Nanang Munif Yasin
Department of Pharmacology, Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, 55281, Indonesia
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Dentistry Education Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 41 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Academic Hospital Journal

 1 
A Study on Lung Cancer Chemotherapy Regimen Administration at Universitas Gadjah Mada Academic Hospital Oktariyanto, Efel Erlambang; Yasin, Nanang Munif; Puspitasari, Ika
Academic Hospital Journal Vol 6, No 2 (2024)
Publisher : Rumah Sakit Akademik Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ahj.v6i2.99663

Abstract

Background: One of the main ways to treat lung cancer is through chemotherapy regimens. Due to the complexity of lung cancer pathophysiology, the variability of chemotherapy given tends to cause drug interactions and toxicity in patients.Objective: Based on this, this study aims to determine the characteristics of lung cancer patients and identify chemotherapy administration patterns based on the NCCN therapy guidelines, identify interactions and side effects of chemotherapy that occur in patients diagnosed with lung cancer who are undergoing outpatient therapy at the Universitas Gadjah Mada Academic Hospital.Method: This research was carried out with a case-series design, namely by conducting a study using descriptive methods that provide an overview of patient characteristics, chemotherapy regimen patterns and their conformity to NCCN guidelines, potential drug-drug interactions (DDIs), and the incidence of side effects experienced by patients. Data was collected retrospectively through medical records of lung cancer patients undergoing outpatient treatment in the period April 2022 – April 2023 who met the inclusion and exclusion criteria.Result: There were a total of 27 patients in this study with patient characteristics predominantly in the elderly age range (> 60 years), 18 patients (66.7%), with exon 19 mutation NSCLC lung cancer type (n = 13; 92.6%), stage IV (n = 25 ; 92.6%), as well as non-smoking patients (n = 15 ; 55.6%). Chemotherapy regimen patterns at Gadjah Mada University Academic Hospital for lung cancer patients included afatinib (n = 14; 51.9%), gefitinib (n = 12; 44.4%), and cisplatin pemetrexed (n = 1; 3.7 %) with conformity reaching 100% in the accuracy of indications, dosage and usage information. In this study, it was identified that there were 2 Potential DDIs that occurred in 1 patient (3.7%) with respective risks, namely C and B which included cisplatin-furosemide and cisplatin-ondansetron interactions. Side effects were known to occur in almost all patients (n = 23; 85.2%) where side effects in the form of skin toxicity and diarrhoea were the two most frequently identified types of side effects with a percentage of 59.3% (n = 16). and 40.7% (n = 11).Conclusion: More than 90% of NSCLC showed exon 19 mutation. The most chemotherapy given to the patients was afatinib. There were a potential interaction between cisplatin and either furosemide or ondansetron.
Co-Authors A., Diki Aprianto Abdul Arief, Thendi Aji Wibowo, Much Ilham Novalisa Ambarsari M., Paulina Andi Ameilia Sari Riandika Anni Anni, Anni As'hari, Yanuar Atana, Sanses Bambang Sigit Riyanto Boku, Yuliana Chairun Wiedyaningsih Desy Purnamasari Dewi, Endah Kusuma Dewi, Endah Kusuma Dina, Amila Djoko Wahyono Eka Kartika Untari Eri Supriyanti Faluti, Dimas Rizki Filliana, Ulfa Fita Rahmawati Fitri, Febiana Melisa Fortuna, Tista Ayu Geografi, Liniati Graciano Aristides Maturbongs Hakim, Sarah Nabila Haninditya, Beta Hasan, Murojil Hastha Yoga, Bambang Hesaji Maranty, Hesaji Hidayatika, Annisa I Dewa Putu Pramantara Ika Puspita Sari Ika Puspitasari Intan Adevia Rosnarita Joko Sunowo, Joko Karundeng, Glory Claudia Kurniawati, Fivy Kurniawati, Fivy Kusumah Wardani, Sintaresmi Kusumaningsih, Riyani Lawalata, Angela Flora Stephanie Listyana, Yanverty Idda Malina, Rachma Marseli, Cindy Maulidiah, Rizka Mazidah, Zulfa Ni’mah, Farihatun Nopita, Rika Nurani, Melisa Rizky Nurficahyanti, Romadhina Nurjanna, Sitti Nurul Safitri Oktariyanto, Efel Erlambang Parera, Maria Meliana Waty Pratama, Tiara Dewi Salindri Probosuseno Probosuseno, Probosuseno Pujilestari, Dwi Puspitasari, Winda Dwi Putri, Mukarromah Dita Putri, Riandita Gusnanda Putri, Wiwin Nopita Rini, Desi Setya Ristyaningsih, Anis Rizka Humardewayanti Asdie Rochmanov, Janne Satibi Satibi Sembiring, Rinawati Setiawati, Margarita Krishna Susi Ari Kristina Titik Nuryastuti Tri Murti Andayani Trung, Vo Quang Wahyu Roossi Ningsih, Wahyu Roossi Wedyaningsih, Chairun Weidyaningsih, Chairun Widyastuti, Herlina Tri Widyastuti, Herlina Tri Widyati, Widyati Widyati Winarni Winarni Wiyatami, Monia Agni Yatminto, Eko Yayi Suryo Prabandari Zaimatuddunia, Irma